AJGP
HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a Colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weber, E.
Right arrow Articles by Reynolds III, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weber, E.
Right arrow Articles by Reynolds III, C. F.
Am J Geriatr Psychiatry 8:245-250, August 2000
© 2000 American Association for Geriatric Psychiatry


Regular Article

Weight Change in Older Depressed Patients During Acute Pharmacotherapy With Paroxetine and Nortriptyline

A Double-Blind Randomized Trial

Elizabeth Weber, C.R.N.P., Jacqueline Stack, M.S.N., Bruce G. Pollock, M.D., Ph.D., Benoit Mulsant, M.D., Amy Begley, M.A., Sati Mazumdar, Ph.D., and Charles F. Reynolds III, M.D.

Received June 28, 1999; revised August 20, 1999; accepted October 4, 1999. From the Intervention Research Center for Late-Life Mood Disorders, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA. Address correspondence to Dr. Reynolds, Western Psychiatric Institute and Clinic, E1135, 3811 O'Hara Street, Pittsburgh, PA 15213. e-mail: ReynoldsCF{at}msx.upmc.edu

The authors examined weight change in 32 elderly patients treated for 12 weeks with either nortriptyline or paroxetine during acute-phase pharmacotherapy. Random assignment to treatment and double-blind assessment of weight change were performed, including ascertainment of premorbid (i.e., pre-depression) weight. Pretreatment severity of depression was correlated with weight loss during the depressive episode and depression-related weight loss, in turn, correlated with weight regained during antidepressant treatment. There was no differential weight change associated with nortriptyline vs. paroxetine. Rather, subjects in both groups approximated their premorbid weights by 12 weeks of acute-phase pharmacotherapy with either agent. However, additional investigation of weight change during continuation and maintenance pharmacotherapy is necessary and would be clinically useful for the long-term management of elderly patients with depression.

Key Words: Antidepressants • Weight Change • Randomized Trials • Paroxetine • Nortriptyline




This article has been cited by other articles:


Home page
QJMHome page
W.S. Leslie, C.R. Hankey, and M.E.J. Lean
Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review
QJM, July 1, 2007; 100(7): 395 - 404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS
Copyright © 2000 American Association for Geriatric Psychiatry